Inhibikase Therapeutics, Inc.

Biotechnology company · Wilmington, Delaware, United States · Nasdaq: IKT

Inhibikase Therapeutics, Inc. is a biotechnology company headquartered in Wilmington, Delaware, United States. Its earliest recorded incorporation is in 2025. Its shares trade on Nasdaq under the ticker IKT. It has received 9 US government small-business research awards (SBIR/STTR) from health agencies, $13 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2026.

www.ablitherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Inhibikase Therapeutics at a glance

Typebiotechnology company

HeadquartersWilmington, Delaware, United States

Earliest incorporation on record2025

Stock listingNasdaq: IKT

SEC industryBiological Products, (No Diagnostic Substances)

Employees (self-reported, 2021)5

SEC CIK1750149, 2104142

What does Inhibikase Therapeutics do?

US government research funding

9 SBIR/STTR small-business research awards from US health agencies, $13.2 million in total (2009 to 2021). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Institute of Allergy and Infectious Diseases, National Cancer Institute.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $1 million sold (2026).

Frequently asked questions about Inhibikase Therapeutics

Where is Inhibikase Therapeutics headquartered?

Inhibikase Therapeutics, Inc. is headquartered in Wilmington, Delaware, United States.

What does Inhibikase Therapeutics do?

Inhibikase Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Inhibikase Therapeutics a public company?

Yes. Inhibikase Therapeutics, Inc. trades on Nasdaq under the ticker IKT.

When was Inhibikase Therapeutics founded?

The earliest incorporation on record for Inhibikase Therapeutics, Inc. is in 2025, according to public company registers.

Similar companies

OpiAID, LLCWilmington, North Carolina, United States
Synnovation Therapeutics, Inc.Wilmington, Delaware, United States
Treadwell CorporationWilmington, North Carolina, United States
NiKang Therapeutics, Inc.Wilmington, Delaware, United States
GPN Vaccines, Inc.Wilmington, Delaware, United States
Advanced Materials Technology, Inc.Wilmington, Delaware, United States
Compact Membrane Systems, Inc.Wilmington, Delaware, United States
StimuSIL, Inc.Wilmington, Delaware, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences